CTRI/2009/091/000854招募中3 期
A prospective, multicenter, randomized, open, comparative clinical trial to test efficacy and safety of 2 brands of highly purified human menopausal gonadotropins in subjects undergoing their first cycle of invitro fertilization with intracytoplasmic sperm injection (ICSI)
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Subjects undergoing first cycle of invitro fertilization with Intracytoplasmic sperm injection (ICSI)
- •2. Subjects aged ≤ 35 years
- •3. BMI between 18 and 30 kg/m2
- •4. subjects with normal FSH and LH levels
- •5. Hysterosalpingography or hysteroscopy documenting a uterus consistent with expected normal function
- •6. Transvaginal ultrasound documenting the presence of both ovaries, without evidence of abnormality
排除标准
- •1. Subjects > 35 years of age.
- •2. Infertility attributable to severe endometriosis (grade III or IV)
- •3. Subjects with previous failed IVF or IVF with ICSI cycle
- •4. Polycystic ovary disease
- •5.Undiagnosed vaginal bleeding
- •6. Tumors and malformation of sexual organs incompatible with pregnancy
研究者
相似试验
招募中
3 期
A comparative clinical trial to test efficacy and safety of 2 brands of highly purified follicle-stimulating hormone in subjects undergoing IVFCTRI/2010/091/000852Bharat Serums and Vaccines Limited100
尚未招募
不适用
A comparative study to verify the usefulness and safety of endoscopic sphincterotomy using (OptimosTM) and foreign-made sphincter incision (CleverCut3V)KCT0006201Yonsei University Health System, Gangnam Severance Hospital104
招募中
1 期
A multi-centre, open, prospective, randomized, parallel-group, 24-month study to compare the outcome of receiving continued immunosuppression versus stopping immunosuppression at 6 months to safely prevent human leukocyte antigen (HLA) sensitization in patients with late renal graft failureRenal transplantationCTIS2023-506879-98-00Vall D'hebron Institut De Recerca202
进行中（未招募）
不适用
An open, randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung malignancy and requiring treatment for air leakage - TachoSil versus standard surgical treatment for air leakage in pulmonary lobectomyEUCTR2004-002380-24-ITYCOMED HEADQUARTER300
进行中（未招募）
不适用
An open randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung malingnancy and requiring treatment for air leakage. - TachoSil versus standard surgical treatment for air leakage in pulmonary lobectomyManagement of pulmonary air leakage following lobectomy in subjects with lung malignancies including metastases.MedDRA version: 8.1Level: PTClassification code 10024741EUCTR2004-002380-24-HUycomed Danmark ApS, International Medical Affairs300